Immediate Versus Early (24-hours) Urinary Catheter Removal After Elective Minimally Invasive Colonic Resection

NCT05249192 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2024-11-29

No results posted yet for this study

Summary

The primary aim of this study is to compare the rate of acute urinary retention (AUR) after immediate compared to early (24-hours) removal of urinary catheter (UC) in patients undergoing minimally invasive colorectal resection. The study hypothesis is that immediate UC removal is non-inferior to 24-hours UC removal in terms of AUR rate.

The secondary outcomes focus on goals that could be positively impacted by the immediate removal of the UC at the end of the surgery. In particular, the rate of urinary tract infections, perception of pain, time-to-return of bowel and physical functions, postoperative complications and postoperative length of stay will all be measured.

Conditions

  • Surgical Complication
  • Colonic Disease
  • Postoperative Complications
  • Urinary Retention Postoperative
  • Urinary Tract Infections

Interventions

DEVICE

Immediate urinary catheter removal

Urinary catheter removal immediately after the end of the surgical procedure before exiting the operating room.

DEVICE

Early urinary catheter removal

urinary catheter removal on the first postoperative day (6 a.m)

Sponsors & Collaborators

  • Faenza Hospital

    collaborator UNKNOWN
  • Ravenna Hospital

    collaborator UNKNOWN
  • Humanitas Research Hospital IRCCS, Rozzano-Milan

    collaborator OTHER
  • Humanitas University

    collaborator UNKNOWN
  • Universita di Verona

    collaborator OTHER
  • Azienda Ospedaliera Universitaria Integrata Verona

    lead OTHER

Principal Investigators

  • Corrado Pedrazzani, Professor · Universita di Verona

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-15
Primary Completion
2024-07-01
Completion
2024-11-26

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05249192 on ClinicalTrials.gov